Ohara M - Search Results

1

The efficacy and safety of preoperative chemotherapy with triweekly abraxane and cyclophosphamide followed by 5-Fluorouracil, epirubicin, and cyclophosphamide therapy for resectable breast cancer: a multicenter clinical trial.

Shigematsu H, Kadoya T, Masumoto N, Sasada T, Emi A, Ohara M, Kajitani K, Okada M. Shigematsu H, et al. Among authors: ohara m. Clin Breast Cancer. 2015 Apr;15(2):110-6. doi: 10.1016/j.clbc.2014.09.010. Epub 2014 Oct 2. Clin Breast Cancer. 2015. PMID: 25454688 Clinical Trial.

2

Dose-finding study of anti-CD25 antibody for targeting regulatory T cells in locoregional immunotherapy of malignant effusion.

Okawaki M, Yamaguchi Y, Okita R, Ohara M, Okada M. Okawaki M, et al. Among authors: ohara m. Hiroshima J Med Sci. 2008 Mar;57(1):37-46. Hiroshima J Med Sci. 2008. PMID: 18578365

3

Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer.

Ohara M, Yamaguchi Y, Matsuura K, Murakami S, Arihiro K, Okada M. Ohara M, et al. Cancer Immunol Immunother. 2009 Mar;58(3):441-7. doi: 10.1007/s00262-008-0570-x. Epub 2008 Aug 7. Cancer Immunol Immunother. 2009. PMID: 18685848 Free PMC article.

4

Targeting of CD4+CD25high cells while preserving CD4+CD25low cells with low-dose chimeric anti-CD25 antibody in adoptive immunotherapy of cancer.

Okita R, Yamaguchi Y, Ohara M, Hironaka K, Okawaki M, Nagamine I, Ikeda T, Emi A, Hihara J, Okada M. Okita R, et al. Among authors: ohara m. Int J Oncol. 2009 Feb;34(2):563-72. Int J Oncol. 2009. PMID: 19148493

5

Induction of gamma delta T cells using zoledronate plus interleukin-2 in patients with metastatic cancer.

Nagamine I, Yamaguchi Y, Ohara M, Ikeda T, Okada M. Nagamine I, et al. Among authors: ohara m. Hiroshima J Med Sci. 2009 Mar;58(1):37-44. Hiroshima J Med Sci. 2009. PMID: 19400555

6

FOXP3 expression of micrometastasis-positive sentinel nodes in breast cancer patients.

Matsuura K, Yamaguchi Y, Osaki A, Ohara M, Okita R, Emi A, Murakami S, Arihiro K. Matsuura K, et al. Among authors: ohara m. Oncol Rep. 2009 Nov;22(5):1181-7. doi: 10.3892/or_00000553. Oncol Rep. 2009. PMID: 19787238

7

Memorial Sloan-Kettering Cancer Center Nomogram to predict the risk of non-sentinel lymph node metastasis in Japanese breast cancer patients.

Sasada T, Murakami S, Kataoka T, Ohara M, Ozaki S, Okada M, Ohdan H. Sasada T, et al. Among authors: ohara m. Surg Today. 2012 Feb;42(3):245-9. doi: 10.1007/s00595-011-0088-2. Epub 2011 Dec 14. Surg Today. 2012. PMID: 22167482

8

Technical feasibility and cosmetic advantage of hybrid endoscopy-assisted breast-conserving surgery for breast cancer patients.

Ozaki S, Ohara M, Shigematsu H, Sasada T, Emi A, Masumoto N, Kadoya T, Murakami S, Kataoka T, Fujii M, Arihiro K, Okada M. Ozaki S, et al. Among authors: ohara m. J Laparoendosc Adv Surg Tech A. 2013 Feb;23(2):91-9. doi: 10.1089/lap.2012.0224. Epub 2012 Dec 28. J Laparoendosc Adv Surg Tech A. 2013. PMID: 23272727

9

[A case of late recurrent breast cancer that responded to radiation therapy and cisplatin plus pemetrexed therapy].

Akimoto E, Ohara M, Noma M, Kamitsuna M, Nishizaka T, Itamoto T. Akimoto E, et al. Among authors: ohara m. Gan To Kagaku Ryoho. 2013 Mar;40(3):371-4. Gan To Kagaku Ryoho. 2013. PMID: 23507601 Japanese.

10

Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer.

Ohara M, Shigematsu H, Tsutani Y, Emi A, Masumoto N, Ozaki S, Kadoya T, Okada M. Ohara M, et al. Breast. 2013 Oct;22(5):958-63. doi: 10.1016/j.breast.2013.05.003. Epub 2013 Jun 10. Breast. 2013. PMID: 23756383

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,415 results

Search Page

Filters